MAGEB10
gene geneOn this page
Also known as FLJ32965
Summary
MAGEB10 (MAGE family member B10, HGNC:25377) is a protein-coding gene on chromosome Xp21.3, encoding Melanoma-associated antigen B10 (Q96LZ2).
This gene encodes a member of the B subfamily of the melanoma associated antigen protein family. The encoded protein is specifically expressed in testis and tumor cells.
Source: NCBI Gene 139422 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 23 total
- MANE Select transcript:
NM_182506
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25377 |
| Approved symbol | MAGEB10 |
| Name | MAGE family member B10 |
| Location | Xp21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32965 |
| Ensembl gene | ENSG00000177689 |
| Ensembl biotype | protein_coding |
| OMIM | 300761 |
| Entrez | 139422 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000356790, ENST00000614159
RefSeq mRNA: 1 — MANE Select: NM_182506
NM_182506
CCDS: CCDS35221
Canonical transcript exons
ENST00000356790 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001408195 | 27821258 | 27823014 |
| ENSE00001479523 | 27817554 | 27817702 |
| ENSE00001479524 | 27807990 | 27808036 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 89.63.
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.63 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.85 | silver quality |
| testis | UBERON:0000473 | 48.35 | gold quality |
| sural nerve | UBERON:0015488 | 47.58 | gold quality |
| right testis | UBERON:0004534 | 47.44 | gold quality |
| left testis | UBERON:0004533 | 45.30 | gold quality |
| cortical plate | UBERON:0005343 | 43.47 | gold quality |
| bone marrow cell | CL:0002092 | 42.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.62 | silver quality |
| ventricular zone | UBERON:0003053 | 40.11 | gold quality |
| bone marrow | UBERON:0002371 | 39.93 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 38.83 | gold quality |
| apex of heart | UBERON:0002098 | 38.67 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| granulocyte | CL:0000094 | 36.18 | gold quality |
| endometrium | UBERON:0001295 | 35.88 | gold quality |
| urinary bladder | UBERON:0001255 | 35.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right coronary artery | UBERON:0001625 | 34.76 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 33.81 | gold quality |
| right lung | UBERON:0002167 | 33.50 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 33.31 | gold quality |
| leukocyte | CL:0000738 | 32.93 | gold quality |
| liver | UBERON:0002107 | 32.93 | gold quality |
| lymph node | UBERON:0000029 | 32.50 | gold quality |
| corpus callosum | UBERON:0002336 | 32.27 | gold quality |
| adrenal tissue | UBERON:0018303 | 31.99 | gold quality |
| monocyte | CL:0000576 | 31.56 | gold quality |
| fundus of stomach | UBERON:0001160 | 31.36 | gold quality |
| left uterine tube | UBERON:0001303 | 31.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting MAGEB10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-5009-3P | 99.45 | 69.43 | 1341 |
| HSA-MIR-4662A-5P | 98.48 | 67.18 | 1007 |
| HSA-MIR-6884-3P | 98.05 | 65.32 | 750 |
| HSA-MIR-1285-5P | 98.01 | 68.71 | 779 |
| HSA-MIR-3159 | 97.94 | 66.79 | 1098 |
| HSA-MIR-483-3P | 97.77 | 64.95 | 731 |
| HSA-MIR-8055 | 97.62 | 66.09 | 1023 |
| HSA-MIR-6760-3P | 96.35 | 68.31 | 1001 |
| HSA-MIR-6879-3P | 93.93 | 64.00 | 759 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ndnl2 | ENSDARG00000058212 |
| drosophila_melanogaster | MAGE | FBGN0037481 |
Paralogs (37): MAGEC2 (ENSG00000046774), TRO (ENSG00000067445), MAGEB2 (ENSG00000099399), MAGED2 (ENSG00000102316), MAGEB4 (ENSG00000120289), MAGEA9 (ENSG00000123584), MAGEA10 (ENSG00000124260), MAGEA4 (ENSG00000147381), MAGED4 (ENSG00000154545), MAGEC1 (ENSG00000155495), MAGEA8 (ENSG00000156009), MAGEC3 (ENSG00000165509), MAGEB6 (ENSG00000176746), MAGEB18 (ENSG00000176774), MAGEF1 (ENSG00000177383), MAGED1 (ENSG00000179222), NDN (ENSG00000182636), MAGEB17 (ENSG00000182798), MAGEA2B (ENSG00000183305), NSMCE3 (ENSG00000185115), MAGEA11 (ENSG00000185247), MAGEE2 (ENSG00000186675), MAGED4B (ENSG00000187243), MAGEH1 (ENSG00000187601), MAGEB5 (ENSG00000188408), MAGEB16 (ENSG00000189023), MAGEA6 (ENSG00000197172), MAGEA1 (ENSG00000198681), MAGEB3 (ENSG00000198798), MAGEE1 (ENSG00000198934), MAGEA12 (ENSG00000213401), MAGEB1 (ENSG00000214107), MAGEA3 (ENSG00000221867), MAGEB6B (ENSG00000232030), MAGEL2 (ENSG00000254585), MAGEA9B (ENSG00000267978), MAGEA2 (ENSG00000268606)
Protein
Protein identifiers
Melanoma-associated antigen B10 — Q96LZ2 (reviewed: Q96LZ2)
Alternative names: MAGE-B10 antigen
All UniProt accessions (1): Q96LZ2
RefSeq proteins (1): NP_872312* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002190 | MHD_dom | Domain |
| IPR021072 | MAGE_N | Domain |
| IPR037445 | MAGE | Family |
| IPR041898 | MAGE_WH1 | Homologous_superfamily |
| IPR041899 | MAGE_WH2 | Homologous_superfamily |
Pfam: PF01454, PF12440
UniProt features (13 total): sequence conflict 3, region of interest 3, compositionally biased region 3, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LZ2-F1 | 72.28 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
chrXp21, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS
GO Biological Process (1): negative regulation of transcription by RNA polymerase II (GO:0000122)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
310 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MAGEB10 | XAGE5 | Q8WWM1 | 570 |
| MAGEB10 | MRFAP1L1 | Q96HT8 | 505 |
| MAGEB10 | IL1RAPL1 | Q9NZN1 | 492 |
| MAGEB10 | PAGE2B | Q5JRK9 | 478 |
| MAGEB10 | KLF12 | Q9Y4X4 | 474 |
| MAGEB10 | AFF2 | P51816 | 473 |
| MAGEB10 | NEUROD2 | Q15784 | 457 |
| MAGEB10 | PRSS55 | Q6UWB4 | 451 |
| MAGEB10 | XAGE3 | Q8WTP9 | 435 |
| MAGEB10 | SPATA3 | Q8NHX4 | 417 |
| MAGEB10 | ZNF135 | P52742 | 398 |
| MAGEB10 | ZC4H2 | Q9NQZ6 | 356 |
| MAGEB10 | TRIM69 | Q86WT6 | 347 |
| MAGEB10 | DDX43 | Q9NXZ2 | 341 |
| MAGEB10 | CAMKV | Q8NCB2 | 337 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GET3 | GET1 | psi-mi:“MI:0914”(association) | 0.640 |
| SUOX | MAGEB10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGEB10 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| EPHA2 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| RAB20 | CHM | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB10 | NSMCE1 | psi-mi:“MI:0914”(association) | 0.530 |
| ARHGAP12 | MAGEB10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| NUDT9 | HARS2 | psi-mi:“MI:0914”(association) | 0.350 |
| UBP1 | TLE4 | psi-mi:“MI:0914”(association) | 0.350 |
| SKA3 | NIN | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A11 | MAGEB10 | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB48 | RPLP0 | psi-mi:“MI:0914”(association) | 0.350 |
| SUOX | MAGEB10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAGEB10 | SUOX | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (104): MAGEB4 (Affinity Capture-MS), NSMCE1 (Affinity Capture-MS), MAGEC2 (Affinity Capture-MS), H2AFX (Affinity Capture-MS), MAGEA10 (Affinity Capture-MS), GOLGA2 (Affinity Capture-MS), C1QBP (Affinity Capture-MS), BRIX1 (Affinity Capture-MS), MRTO4 (Affinity Capture-MS), SDAD1 (Affinity Capture-MS), RPL26L1 (Affinity Capture-MS), RPL3 (Affinity Capture-MS), NOC2L (Affinity Capture-MS), STAU1 (Affinity Capture-MS), KIAA0020 (Affinity Capture-MS)
ESM2 similar proteins: A0A0J9YX57, A1A5P9, A2A368, A2A9R3, A8MXT2, B2KFW1, O15479, O15480, O15481, O15553, P0C6Y7, P10073, P17040, P25233, P43355, P43356, P43357, P43358, P43360, P43362, P43363, P43364, P43366, Q13342, Q16666, Q4R998, Q5PPP4, Q5RD14, Q6AY37, Q6PCZ4, Q8BQR7, Q8IWY8, Q8IX06, Q8N660, Q8N7X4, Q8TD90, Q96DU7, Q96LZ2, Q96M61, Q99608
Diamond homologs: A0A0J9YX57, A1A5P9, A2A368, A2A9R3, A6NCF6, A6QLI5, A8MXT2, O15479, O15480, O15481, O60732, P25233, P43355, P43356, P43357, P43358, P43360, P43361, P43362, P43363, P43364, P43365, P43366, Q12816, Q4R998, Q5PPP4, Q5RFC2, Q6AY37, Q6ITT4, Q6PCZ4, Q8BQR7, Q8N7X4, Q8TD90, Q8TD91, Q96JG8, Q96LZ2, Q96M61, Q96MG7, Q99608, Q9BE18
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
279 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:27821254:CCA:C | acceptor_loss | 0.9800 |
| X:27821255:CA:C | acceptor_loss | 0.9800 |
| X:27821256:A:AC | acceptor_loss | 0.9800 |
| X:27821256:A:AG | acceptor_gain | 0.9800 |
| X:27821257:G:GC | acceptor_loss | 0.9800 |
| X:27821257:G:GG | acceptor_gain | 0.9800 |
| X:27821257:GGT:G | acceptor_gain | 0.9600 |
| X:27821256:AG:A | acceptor_gain | 0.9500 |
| X:27821257:GG:G | acceptor_gain | 0.9500 |
| X:27821257:GGTC:G | acceptor_gain | 0.9400 |
| X:27821257:GGTCA:G | acceptor_gain | 0.9300 |
| X:27817703:G:GG | donor_gain | 0.8700 |
| X:27812927:GC:G | donor_gain | 0.8600 |
| X:27810216:G:A | acceptor_gain | 0.8100 |
| X:27808032:AGGAG:A | donor_loss | 0.8000 |
| X:27808035:AGGT:A | donor_loss | 0.8000 |
| X:27808036:GGTAA:G | donor_loss | 0.8000 |
| X:27808037:GT:G | donor_loss | 0.8000 |
| X:27808038:T:G | donor_loss | 0.8000 |
| X:27812772:AC:A | donor_gain | 0.8000 |
| X:27808033:GGAG:G | donor_gain | 0.7900 |
| X:27808034:GAGG:G | donor_gain | 0.7900 |
| X:27819775:GCC:G | donor_gain | 0.7900 |
| X:27808188:G:T | donor_gain | 0.7700 |
| X:27808039:AAG:A | donor_loss | 0.7600 |
| X:27818772:TG:T | donor_gain | 0.7300 |
| X:27818773:GG:G | donor_gain | 0.7300 |
| X:27820029:T:TA | acceptor_gain | 0.7300 |
| X:27812934:A:T | donor_gain | 0.7000 |
| X:27817553:G:C | acceptor_gain | 0.6700 |
AlphaMissense
2285 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:27822129:T:A | W275R | 0.985 |
| X:27822129:T:C | W275R | 0.985 |
| X:27822124:T:C | F273S | 0.975 |
| X:27822177:T:C | F291L | 0.975 |
| X:27822179:T:A | F291L | 0.975 |
| X:27822179:T:G | F291L | 0.975 |
| X:27822132:G:C | G276R | 0.972 |
| X:27821796:T:C | F164L | 0.971 |
| X:27821798:T:A | F164L | 0.971 |
| X:27821798:T:G | F164L | 0.971 |
| X:27822131:G:C | W275C | 0.967 |
| X:27822131:G:T | W275C | 0.967 |
| X:27822161:G:C | K285N | 0.962 |
| X:27822161:G:T | K285N | 0.962 |
| X:27822133:G:A | G276D | 0.952 |
| X:27821803:T:C | L166P | 0.950 |
| X:27822027:T:C | F241L | 0.949 |
| X:27822029:T:A | F241L | 0.949 |
| X:27822029:T:G | F241L | 0.949 |
| X:27822183:G:C | A293P | 0.944 |
| X:27821785:T:C | L160P | 0.943 |
| X:27821681:G:C | K125N | 0.941 |
| X:27821681:G:T | K125N | 0.941 |
| X:27822123:T:C | F273L | 0.941 |
| X:27822125:C:A | F273L | 0.941 |
| X:27822125:C:G | F273L | 0.941 |
| X:27822141:G:C | A279P | 0.940 |
| X:27821976:T:A | W224R | 0.939 |
| X:27821976:T:C | W224R | 0.939 |
| X:27822172:T:A | L289H | 0.939 |
dbSNP variants (sampled 300 via entrez): RS1000211395 (X:27822603 G>A), RS1000322499 (X:27822932 G>A), RS1000387714 (X:27814864 CTT>C,CTTT), RS1000878544 (X:27812667 G>A), RS1001330618 (X:27817914 G>A), RS1001389264 (X:27817273 T>C,G), RS1001736205 (X:27807810 A>G), RS1001997389 (X:27809916 C>T), RS1002334753 (X:27820185 C>G), RS1002346514 (X:27810289 C>T), RS1002387049 (X:27819534 G>A), RS1002767406 (X:27819448 A>G), RS1002986928 (X:27810254 G>A,C), RS1003294900 (X:27819910 G>A), RS1003411088 (X:27811708 A>C,G)
Disease associations
OMIM: gene MIM:300761 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.